Chief Financial Officer · Fulgent Genetics, Inc. (FLGT)

Paul Kim

FY2025 is the first fiscal year CompBrief holds for Paul Kim as a named executive officer of Fulgent Genetics; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$2,773,352

Compensation figures as of the proxy filed March 31, 2026 (DEF 14A). Insider transactions since that proxy, current to 2026-09-24.

Paul Kim compensation by year

Fulgent Genetics Summary Compensation Table · the one fiscal year held
In US dollars, as Fulgent Genetics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$600,000
Bonus$0
Stock awards$1,800,000
Option awards$0
Non-equity incentive$325,890
Pension and deferred compensation$0
All other$47,462
Total$2,773,352

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Fulgent Genetics, Inc. DEF 14A filed March 31, 2026, accession 0001674930-26-000020, and prior-year filings. Open the filing on EDGAR.

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU153,459$4,031,368—

Per the Outstanding Equity Awards at Fiscal Year-End table in Fulgent Genetics, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

6 Form 4 lines since the FY2025 proxy (filed March 31, 2026)
current to 2026-09-24 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-09-01Tax withholding—2,087$19.59356,543
2026-08-26Tax withholding—1,168$19.81358,630
2026-07-26Tax withholding—2,747$19.67359,798
2026-06-01Tax withholding—2,087$18.09362,545
2026-05-26Tax withholding—1,168$17.67364,632
2026-04-26Tax withholding—2,747$16.31365,800

The 6 most recent of 6 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Fulgent Genetics’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Ming HsiehChief Executive Officer and Chairperson of the Board$6,207,000
Jian XiePresident and Chief Operating Officer$2,807,658
Paul Kim · this pageChief Financial Officer$2,773,352

The full Fulgent Genetics compensation record

free company brief

This page is one person within Fulgent Genetics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Fulgent Genetics's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Fulgent Genetics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy